Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$521M |
| 2 |
Becton Dickinson
BDX
|
+$411M |
| 3 |
GE Aerospace
GE
|
+$361M |
| 4 |
IBM
IBM
|
+$305M |
| 5 |
Philip Morris
PM
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$455M |
| 2 |
NetEase
NTES
|
+$451M |
| 3 |
Medtronic
MDT
|
+$398M |
| 4 |
NVIDIA
NVDA
|
+$348M |
| 5 |
Netflix
NFLX
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.06% |
| 2 | Technology | 13.71% |
| 3 | Financials | 10.21% |
| 4 | Industrials | 9.72% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
First Financial Corp
THFF
$975M
| $8.19M | 0.01% |
180,500
-4,500
| -2% | -$213K |
|
1502
Brookdale Senior Living
BKD
$3B
| $8.15M | 0.01% |
+839,818
| New | +$8.56M |
|
|
HTLF
1503
DELISTED
Heartland Financial USA, Inc.
HTLF
| $8.14M | 0.01% |
151,800
-27,200
| -15% | -$1.37M |
|
1504
Minerals Technologies
MTX
$2.26B
| $8.14M | 0.01% |
118,200
+49,500
| +72% | +$3.52M |
|
|
AEL
1505
DELISTED
American Equity Investment Life Holding Company
AEL
| $8.12M | 0.01% |
264,300
+232,100
| +721% | +$7.04M |
|
|
TESS
1506
DELISTED
Tessco Technologies Inc
TESS
| $8.11M | 0.01% |
402,700
+10,100
| +3% | +$160K |
|
|
ABAX
1507
DELISTED
Abaxis Inc
ABAX
| $8.07M | 0.01% |
162,971
+40,700
| +33% | +$1.94M |
|
|
PRTK
1508
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $8.07M | 0.01% |
450,649
+79,911
| +22% | +$1.67M |
|
|
BLMT
1509
DELISTED
BSB Bancorp, Inc.
BLMT
| $8.06M | 0.01% |
275,660
+14,460
| +6% | +$439K |
|
|
CBPO
1510
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $8.06M | 0.01% |
102,300
-99,800
| -49% | -$8.3M |
|
1511
Tilly's
TLYS
$122M
| $8.05M | 0.01% |
545,200
+17,900
| +3% | +$240K |
|
|
AUY
1512
DELISTED
Yamana Gold, Inc.
AUY
| $8.04M | 0.01% |
+2,578,000
| New | +$6.88M |
|
1513
Madrigal Pharmaceuticals
MDGL
$11.7B
| $8.04M | 0.01% |
87,587
-39,700
| -31% | -$2.27M |
|
1514
Titan Machinery
TITN
$420M
| $8.03M | 0.01% |
379,447
+339,047
| +839% | +$5.83M |
|
|
SVU
1515
DELISTED
SUPERVALU Inc.
SVU
| $8M | 0.01% |
370,555
+6,500
| +2% | +$119K |
|
1516
Belden
BDC
$5.36B
| $8M | 0.01% |
103,700
+14,000
| +16% | +$1.16M |
|
1517
Boston Beer
SAM
$1.9B
| $7.99M | 0.01% |
41,800
+31,200
| +294% | +$5.57M |
|
|
CYS
1518
DELISTED
CYS Investments Inc.
CYS
| $7.98M | 0.01% |
993,700
-156,529
| -14% | -$1.29M |
|
|
PZN
1519
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $7.97M | 0.01% |
747,200
+52,800
| +8% | +$592K |
|
1520
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17.1B
| $7.97M | 0.01% |
+78,500
| New | +$7.99M |
|
|
TEF
1521
DELISTED
Telefonica
TEF
| $7.97M | 0.01% |
1,019,194
+491,958
| +93% | +$4.04M |
|
|
MFSF
1522
DELISTED
MutualFirst Financial Inc
MFSF
| $7.96M | 0.01% |
206,500
+7,404
| +4% | +$286K |
|
1523
TechTarget
TTGT
$277M
| $7.96M | 0.01% |
571,453
+26,283
| +5% | +$342K |
|
1524
Information Services Group
III
$250M
| $7.94M | 0.01% |
1,903,811
+31,200
| +2% | +$130K |
|
1525
DuPont de Nemours
DD
$19.5B
| $7.93M | 0.01% |
43,986
-598,442
| -93% | -$108M |
|
Similar funds
Jim Simons's Q4 2017 Portfolio in Review
As of Q4 2017, Jim Simons held 3,692 positions worth $90.7B, up 6.7% from $85B the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.
Jim Simons's Q4 2017 filing shows 521 new, 1,724 increased, 1,031 reduced and 386 closed positions. Its largest new stake was Alphabet (Google) Class C: 3,773,700 shares worth $197M. The largest sale was CR Bard Inc., an estimated $455M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Jim Simons's largest Q4 2017 buy was Alphabet (Google) Class C: 3,773,700 shares worth $197M.
- Jim Simons added most to ExxonMobil in Q4 2017, an estimated $521M increase.
- Jim Simons's biggest Q4 2017 reduction was NetEase, cutting an estimated $451M.
- Jim Simons fully exited CR Bard Inc. in Q4 2017, selling an estimated $455M.
- Jim Simons's ten largest holdings make up 8.4% of its $90.7B portfolio in Q4 2017.
- Jim Simons opened 521 new positions and closed 386 in Q4 2017.
- Jim Simons's portfolio value rose 6.7% quarter-over-quarter to $90.7B.
Based on Renaissance Technologies's 13F filing for Q4 2017, filed 13 Feb 2018.